Shares of Addus HomeCare Corporation (NASDAQ:ADUS – Get Free Report) have been given a consensus rating of “Buy” by the eight brokerages that are currently covering the company, Marketbeat Ratings reports. Six research analysts have rated the stock with a buy rating and two have issued a strong buy rating on the company. The average 12 month price target among brokers that have covered the stock in the last year is $142.57.
A number of analysts have recently weighed in on ADUS shares. Macquarie reaffirmed an “outperform” rating and issued a $133.00 price target on shares of Addus HomeCare in a research note on Tuesday, June 10th. JMP Securities reaffirmed a “market outperform” rating and issued a $150.00 price target on shares of Addus HomeCare in a research note on Friday, June 20th. Stephens reaffirmed an “overweight” rating and issued a $142.00 price target on shares of Addus HomeCare in a research note on Wednesday, March 12th. Finally, Wall Street Zen lowered shares of Addus HomeCare from a “buy” rating to a “hold” rating in a research note on Saturday, June 21st.
Read Our Latest Research Report on ADUS
Insider Buying and Selling
Institutional Trading of Addus HomeCare
Hedge funds and other institutional investors have recently made changes to their positions in the business. New York State Common Retirement Fund raised its holdings in shares of Addus HomeCare by 6.0% during the fourth quarter. New York State Common Retirement Fund now owns 14,098 shares of the company’s stock valued at $1,767,000 after acquiring an additional 800 shares during the period. Handelsbanken Fonder AB raised its holdings in shares of Addus HomeCare by 17.2% during the fourth quarter. Handelsbanken Fonder AB now owns 4,083 shares of the company’s stock valued at $512,000 after acquiring an additional 600 shares during the period. Y Intercept Hong Kong Ltd acquired a new stake in shares of Addus HomeCare during the fourth quarter valued at approximately $258,000. Illinois Municipal Retirement Fund raised its holdings in shares of Addus HomeCare by 2.4% during the fourth quarter. Illinois Municipal Retirement Fund now owns 9,657 shares of the company’s stock valued at $1,211,000 after acquiring an additional 223 shares during the period. Finally, Oppenheimer & Co. Inc. raised its holdings in shares of Addus HomeCare by 21.0% during the fourth quarter. Oppenheimer & Co. Inc. now owns 6,038 shares of the company’s stock valued at $757,000 after acquiring an additional 1,047 shares during the period. 95.35% of the stock is currently owned by institutional investors.
Addus HomeCare Trading Down 0.4%
Shares of NASDAQ:ADUS opened at $115.12 on Wednesday. The company has a market cap of $2.12 billion, a PE ratio of 25.99, a P/E/G ratio of 1.64 and a beta of 0.81. The company’s 50-day moving average price is $110.24 and its 200 day moving average price is $111.72. Addus HomeCare has a fifty-two week low of $88.96 and a fifty-two week high of $136.72. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.20.
Addus HomeCare (NASDAQ:ADUS – Get Free Report) last released its quarterly earnings results on Monday, May 5th. The company reported $1.42 EPS for the quarter, topping analysts’ consensus estimates of $1.33 by $0.09. The company had revenue of $337.71 million for the quarter, compared to the consensus estimate of $341.66 million. Addus HomeCare had a net margin of 6.52% and a return on equity of 9.23%. Addus HomeCare’s revenue was up 20.3% on a year-over-year basis. During the same period in the previous year, the firm earned $1.21 EPS. Sell-side analysts anticipate that Addus HomeCare will post 4.59 earnings per share for the current year.
About Addus HomeCare
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Featured Stories
- Five stocks we like better than Addus HomeCare
- Overbought Stocks Explained: Should You Trade Them?
- EA Just Caught a Monster Upgrade: Bullish Breakout Ahead?
- Energy and Oil Stocks Explained
- 3 Stocks Hitting All-Time Highs With More Room to Run
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- QuantumScape Soars 30%: What Drove the Next-Gen EV Stock’s Rally
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.